| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 440.1K | $19.61M | -64,000 | |
| Other | 138.6K | $6.17M | - | |
| Other | 123.1K | $5.48M | - | |
| CFO | 116.9K | $5.21M | -1,014 | |
| Other | 111.5K | $4.97M | -1,018 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Inrig Jula45 | Chief Medical Officer | Sell | 684 | $12.98 | $8,878.32 | -1.1% | +46.2% | +112.7% | |
| Sep 9, 2024 | Rote William E.58 | Senior Vice President, R&D | Sell | 4,387 | $11.52 | $50,538.24 | -4.9% | +46.0% | +68.3% | |
| Sep 9, 2024 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 4,387 | $11.52 | $50,538.24 | -5.3% | +46.0% | +68.3% | |
| Sep 9, 2024 | Dube Eric M57 | Chief Executive Officer | Sell | 21,125 | $11.52 | $243,360.00 | -5.5% | +46.0% | +68.3% | |
| Sep 9, 2024 | Inrig Jula45 | Chief Medical Officer | Sell | 2,191 | $11.52 | $25,240.32 | -3.4% | +46.0% | +68.3% | |
| Sep 9, 2024 | Heerma Peter53 | Chief Commercial Officer | Sell | 2,191 | $11.52 | $25,240.32 | -2.0% | +46.0% | +68.3% | |
| Sep 9, 2024 | Cline Christopher R.50 | Chief Financial Officer | Sell | 2,490 | $11.52 | $28,684.80 | -3.2% | +46.0% | +68.3% | |
| Sep 4, 2024 | Cline Christopher R.50 | Chief Financial Officer | Sell | 514 | $9.51 | $4,887.78 | -0.7% | +92.8% | +110.4% | |
| Apr 11, 2024 | Cline Christopher R.50 | Chief Financial Officer | Sell | 54 | $6.74 | $363.96 | - | +42.5% | +116.7% | |
| Feb 1, 2024 | Rote William E.58 | Senior Vice President, R&D | Sell | 4,764 | $8.71 | $41,495.10 | -2.8% | -30.2% | +137.9% |